Patents by Inventor Annamaria Vezzani

Annamaria Vezzani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150190404
    Abstract: This invention relates to methods and compositions for treating or preventing seizures.
    Type: Application
    Filed: December 18, 2014
    Publication date: July 9, 2015
    Inventors: Annamaria Vezzani, John Randle
  • Publication number: 20100168215
    Abstract: The present invention relates to a method for delivering a nucleic acid sequence encoding neuropeptide Y, or a derivative or functional fragment thereof, to a mammalian nervous system target cell. The expression of exogenous NPY, or a derivative or a functional fragment thereof in the target cell(s) provides therapeutic benefit for subjects afflicted with a neurological disorder.
    Type: Application
    Filed: March 1, 2010
    Publication date: July 1, 2010
    Applicant: NEUROLOGIX, INC.
    Inventors: Matthew J. During, Annamaria Vezzani
  • Patent number: 7723288
    Abstract: The present invention relates to a method for delivering a nucleic acid sequence encoding neuropeptide Y, or a derivative or functional fragment thereof, to a mammalian nervous system target cell. The expression of exogenous NPY, or a derivative or a functional fragment thereof in the target cell(s) provides therapeutic benefit for subjects afflicted with a neurological disorder.
    Type: Grant
    Filed: October 14, 2004
    Date of Patent: May 25, 2010
    Assignee: Neurologix, Inc.
    Inventors: Matthew J. During, Annamaria Vezzani
  • Publication number: 20070218084
    Abstract: A method for functionally identifying an epileptogenic focus in pre-surgical evaluation in affected subjects with intractable epilepsy is described, the method including the delivery of an effective dose of a botulinum neurotoxin (BoNT) to a presumptive epileptogenic focus in the disease-compromised central nervous system of a mammal, under conditions whereby the effective dose of the botulinum neurotoxin interacts with the soluble N-ethylmaleimide-sensitive factor-attachment receptor (SNARE) proteins, thus impairing neurotransmission.
    Type: Application
    Filed: January 16, 2007
    Publication date: September 20, 2007
    Applicant: Fondazione Pierfranco e Luisa Mariani- ONLUS
    Inventors: Matteo Caleo, Yuri Bozzi, Laura Costantin, Cristina Richichi, Alessandro Viegi, Flavia Antonucci, Marcella Funicello, Marco Gobbi, Tiziana Mennini, Ornella Rossetto, Cesare Montecucco, Lamberto Maffei, Annamaria Vezzani
  • Publication number: 20060128696
    Abstract: This invention relates to methods and compositions for treating or preventing seizures.
    Type: Application
    Filed: May 16, 2005
    Publication date: June 15, 2006
    Inventors: Annamaria Vezzani, John Randle
  • Publication number: 20050136036
    Abstract: The present invention relates to a method for delivering a nucleic acid sequence encoding neuropeptide Y, or a derivative or functional fragment thereof, to a mammalian nervous system target cell. The expression of exogenous NPY, or a derivative or a functional fragment thereof in the target cell(s) provides therapeutic benefit for subjects afflicted with a neurological disorder.
    Type: Application
    Filed: October 14, 2004
    Publication date: June 23, 2005
    Inventors: Matthew During, Annamaria Vezzani